TP53 and ovarian clear cell cancer: Using wild-type p53-expressing ovarian clear cell carcinoma cell lines in the current study, we demonstrate in a preclinical tumor cell plus T-cell co-culture system that high MDM2-expressing human ovarian cancer cell lines are relatively resistant to T-cell-mediated tumor cell killing.